Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/23/1998WO1998057940A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998WO1998057939A1 Crystalline roxifiban
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998WO1998057932A1 New amidino derivatives and their use as thrombin inhibitors
12/23/1998WO1998057917A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
12/23/1998WO1998057661A1 Therapeutic composition and method of treatment
12/23/1998WO1998057652A1 Polyallylamine polymers for treating hypercholesterolemia
12/23/1998WO1998057649A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
12/23/1998WO1998057642A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057641A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057640A1 Alpha 1a adrenergic receptor antagonists
12/23/1998WO1998057639A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057638A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057637A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
12/23/1998WO1998057634A1 Treatment of diabetes with thiazolidinedione and metformin
12/23/1998WO1998057633A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
12/23/1998WO1998057632A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/23/1998WO1998057627A1 Dietary compositions for enhancing metabolism and alleviating oxidative stress
12/23/1998WO1998057622A1 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation
12/23/1998WO1998045241A3 Lutein esters having high bioavailability
12/23/1998WO1998042327A3 Vascular remodeling agent
12/23/1998EP0885966A2 Novel compouds
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885956A1 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro) biological production of proteins
12/23/1998EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy
12/23/1998EP0885889A2 Process for the preparation of pyrazole-3-carboxylic acids
12/23/1998EP0885308A1 Compositions and methods of making embryonic stem cells
12/23/1998EP0885301A1 Down-regulation resistant c3 convertase
12/23/1998EP0885299A1 Wsx receptor and ligands
12/23/1998EP0885230A1 Camptothecin derivatives and the use thereof as antitumor agents
12/23/1998EP0885228A1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
12/23/1998EP0885227A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION
12/23/1998EP0885226A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production
12/23/1998EP0885217A1 Endothelin receptor antagonists
12/23/1998EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/23/1998EP0885213A1 Fibrinogen receptor antagonists
12/23/1998EP0885212A1 Quinoxalinediones
12/23/1998EP0885211A1 Compounds with a sulfamate group
12/23/1998EP0885210A1 Tricyclic compounds, their production and use
12/23/1998EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
12/23/1998EP0885193A1 Triaryl compounds
12/23/1998EP0885192A1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
12/23/1998EP0885011A2 Vaccines
12/23/1998EP0885009A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists
12/23/1998EP0885004A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers
12/23/1998EP0722459B1 Hemoregulatory penta- or hexapeptides
12/23/1998EP0701546B1 Aromatic acetylcholinesterase inhibitors
12/23/1998EP0610368B1 Treatment of acne or of pseudofolliculitis barbae
12/23/1998EP0494914B1 2-spirocyclopropyl cephalosporin derivatives and processes for the preparation thereof
12/23/1998CN1202934A Delivery of biologically active polypeptides
12/23/1998CN1202907A Cyclopeptide derivatives
12/23/1998CN1202901A Phosphonic acid derivatives with metallopeptidase inhibitory activity
12/23/1998CN1202895A Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalluproteinass (MMP) and/or tumour necrosis factor (TNF)
12/23/1998CN1202894A Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CN1202825A Protein kinase C inhibitor
12/23/1998CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
12/23/1998CN1202369A Smoking stopping powder for whole life
12/23/1998CN1041311C Method for preparing benzopyran and related LTB4 antagonists
12/23/1998CA2430623A1 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
12/23/1998CA2295994A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998CA2295207A1 Hammerhead ribozymes with extended cleavage rule
12/23/1998CA2294724A1 Method for producing medicaments containing hmg-coa-reductase inhibitors
12/23/1998CA2294591A1 Alpha 1a adrenergic receptor antagonists
12/23/1998CA2294590A1 Alpha 1a adrenergic receptor antagonists
12/23/1998CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998CA2294549A1 Heterocyclic substituted piperidines and uses thereof
12/23/1998CA2294519A1 Peptides and compounds that bind to the il-5 receptor
12/23/1998CA2294379A1 3-benzylpiperidine
12/23/1998CA2294349A1 Alpha 1aadrenergic receptor antagonists
12/23/1998CA2294346A1 Alpha 1a adrenergic receptor antagonists
12/23/1998CA2294344A1 Alpha 1a adrenergic receptor antagonists
12/23/1998CA2294281A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
12/23/1998CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998CA2294047A1 Crystalline roxifiban
12/23/1998CA2293735A1 Lag-3 splice variants
12/23/1998CA2293482A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
12/23/1998CA2293449A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
12/23/1998CA2293408A1 Alpha 1a adrenergic receptor antagonists
12/23/1998CA2292912A1 Therapeutic composition and method of treatment
12/23/1998CA2292883A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998CA2241164A1 Apo b-secretion/mtp inhibitor hydrochloride salt
12/22/1998US5852190 Diazepinoindoles as phosphodiesterase IV inhibitors
12/22/1998US5852188 Oligonucleotides having chiral phosphorus linkages
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy
12/22/1998US5852049 Aromatic ethers derived from indoles which are useful as medicaments
12/22/1998US5852047 Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
12/22/1998US5852044 Use of NK1 receptor antagonists for preparing cardio-regulatory drugs
12/22/1998US5852043 HIV protease inhibitors
12/22/1998US5852034 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
12/22/1998US5852033 Methods of treatment using lamellarin-class alkaloids
12/22/1998US5852031 2,7-substituted octahydro-1H-pyrido 1,2-a!pyrazine derivatives
12/22/1998US5852007 Cysteine and serine protease inhibitors containing D-amino acid at the P2 position, methods of making same, and methods of using same
12/22/1998US5852004 Drug and pharmaceutical composition for the treatment of lesions of the digestive tract
12/22/1998US5851996 Materials and methods for treatment of plaquing diseases
12/22/1998US5851990 bFGF mutein and its production
12/22/1998US5851986 Promoting bone formation and inhibiting bone resorption with high mobility group protein-1 (HMG-1)
1 ... 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 ... 1564